Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Dual Effect of Taxifolin on ZEB2 Cancer Signaling in HepG2 Cells

Z. Dostal, M. Sebera, J. Srovnal, K. Staffova, M. Modriansky

. 2021 ; 26 (5) : . [pub] 20210309

Language English Country Switzerland

Document type Journal Article

Grant support
RVO 61989592 Ministry of Education of the Czech Republic
IGA_LF_2020_022 Palacký University

Polyphenols, secondary metabolites of plants, exhibit different anti-cancer and cytoprotective properties such as anti-radical, anti-angiogenic, anti-inflammation, or cardioprotective. Some of these activities could be linked to modulation of miRNAs expression. MiRNAs play an important role in posttranscriptional regulation of their target genes that could be important within cell signalling or preservation of cell homeostasis, e.g., cell survival/apoptosis. We evaluated the influence of a non-toxic concentration of taxifolin and quercetin on the expression of majority human miRNAs via Affymetrix GeneChip™ miRNA 3.0 Array. For the evaluation we used two cell models corresponding to liver tissue, Hep G2 and primary human hepatocytes. The array analysis identified four miRNAs, miR-153, miR-204, miR-211, and miR-377-3p, with reduced expression after taxifolin treatment. All of these miRNAs are linked to modulation of ZEB2 expression in various models. Indeed, ZEB2 protein displayed upregulation after taxifolin treatment in a dose dependent manner. However, the modulation did not lead to epithelial mesenchymal transition. Our data show that taxifolin inhibits Akt phosphorylation, thereby diminishing ZEB2 signalling that could trigger carcinogenesis. We conclude that biological activity of taxifolin may have ambiguous or even contradictory outcomes because of non-specific effect on the cell.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019076
003      
CZ-PrNML
005      
20211221135549.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules26051476 $2 doi
035    __
$a (PubMed)33803107
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dostál, Zdeněk $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic $7 xx0267686
245    10
$a Dual Effect of Taxifolin on ZEB2 Cancer Signaling in HepG2 Cells / $c Z. Dostal, M. Sebera, J. Srovnal, K. Staffova, M. Modriansky
520    9_
$a Polyphenols, secondary metabolites of plants, exhibit different anti-cancer and cytoprotective properties such as anti-radical, anti-angiogenic, anti-inflammation, or cardioprotective. Some of these activities could be linked to modulation of miRNAs expression. MiRNAs play an important role in posttranscriptional regulation of their target genes that could be important within cell signalling or preservation of cell homeostasis, e.g., cell survival/apoptosis. We evaluated the influence of a non-toxic concentration of taxifolin and quercetin on the expression of majority human miRNAs via Affymetrix GeneChip™ miRNA 3.0 Array. For the evaluation we used two cell models corresponding to liver tissue, Hep G2 and primary human hepatocytes. The array analysis identified four miRNAs, miR-153, miR-204, miR-211, and miR-377-3p, with reduced expression after taxifolin treatment. All of these miRNAs are linked to modulation of ZEB2 expression in various models. Indeed, ZEB2 protein displayed upregulation after taxifolin treatment in a dose dependent manner. However, the modulation did not lead to epithelial mesenchymal transition. Our data show that taxifolin inhibits Akt phosphorylation, thereby diminishing ZEB2 signalling that could trigger carcinogenesis. We conclude that biological activity of taxifolin may have ambiguous or even contradictory outcomes because of non-specific effect on the cell.
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a pohyb buněk $x účinky léků $7 D002465
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a epitelo-mezenchymální tranzice $x genetika $7 D058750
650    _2
$a exprese genu $x účinky léků $x genetika $7 D015870
650    _2
$a regulace genové exprese u nádorů $x účinky léků $7 D015972
650    _2
$a buňky Hep G2 $x metabolismus $7 D056945
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a mikro RNA $x účinky léků $x genetika $7 D035683
650    _2
$a polyfenoly $x farmakologie $7 D059808
650    _2
$a primární buněčná kultura $7 D061251
650    _2
$a quercetin $x analogy a deriváty $x metabolismus $x farmakologie $7 D011794
650    _2
$a signální transdukce $x genetika $7 D015398
650    _2
$a transkriptom $x účinky léků $x genetika $7 D059467
650    _2
$a transkripční faktor Zeb2 $x účinky léků $x metabolismus $7 D000074165
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sebera, Martin $u Faculty of Sport Studies, Masaryk University, 60177 Brno, Czech Republic
700    1_
$a Srovnal, Josef $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic
700    1_
$a Staffova, Katerina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic
700    1_
$a Modriansky, Martin $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, 77515 Olomouc, Czech Republic
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 5 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33803107 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20211221135544 $b ABA008
999    __
$a ok $b bmc $g 1689997 $s 1139522
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 5 $e 20210309 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a RVO 61989592 $p Ministry of Education of the Czech Republic
GRA    __
$a IGA_LF_2020_022 $p Palacký University
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...